Chapter 1. Introduction (2025-2033)
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (2025-2033)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary (2025-2033)
3.1. Market Snapshot
Chapter 4. Market Variables and Scope (2025-2033)
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Personalized Medicine Market (2025-2033)
5.1. COVID-19 Landscape: Personalized Medicine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends (2025-2033)
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape (2025-2033)
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Personalized Medicine Market, By Product (2025-2033)
8.1. Personalized Medicine Market, by Product Type, (2025-2033)
8.1.1. Personalized Medicine Diagnostics (Genetic Testing, DTC Diagnostics, Esoteric Lab Services, Esoteric Lab Tests)
8.1.1.1. Market Revenue and Forecast (2025-2033)
8.1.2. Personalized Medicine Therapeutics (Pharmaceutical, Genomic Medicine, Medical Devices)
8.1.2.1. Market Revenue and Forecast (2025-2033)
8.1.3. Personalized Medical Care (Telemedicine, Health Information Technology)
8.1.3.1. Market Revenue and Forecast (2025-2033)
8.1.4. Personalized Nutrition and Wellness (Retail Nutrition, Complementary & Alternative Medicine)
8.1.4.1. Market Revenue and Forecast (2025-2033)
Chapter 9. Global Personalized Medicine Market, By End-use (2025-2033)
9.1. Personalized Medicine Market, by End-use, (2025-2033)
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2025-2033)
9.1.2. Diagnostic Centers
9.1.2.1. Market Revenue and Forecast (2025-2033)
9.1.3. Research & Academic Institutes
9.1.3.1. Market Revenue and Forecast (2025-2033)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2025-2033)
Chapter 10. Global Personalized Medicine Market, Regional Estimates and Trend Forecast (2025-2033)
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2025-2033)
10.1.2. Market Revenue and Forecast, by Application (2025-2033)
10.1.3. Market Revenue and Forecast, by End-use (2025-2033)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2025-2033)
10.1.4.2. Market Revenue and Forecast, by Application (2025-2033)
10.1.4.3. Market Revenue and Forecast, by End-use (2025-2033)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2025-2033)
10.1.5.2. Market Revenue and Forecast, by Application (2025-2033)
10.1.5.3. Market Revenue and Forecast, by End-use (2025-2033)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2025-2033)
10.2.2. Market Revenue and Forecast, by Application (2025-2033)
10.2.3. Market Revenue and Forecast, by End-use (2025-2033)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2025-2033)
10.2.4.2. Market Revenue and Forecast, by Application (2025-2033)
10.2.4.3. Market Revenue and Forecast, by End-use (2025-2033)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2025-2033)
10.2.5.2. Market Revenue and Forecast, by Application (2025-2033)
10.2.5.3. Market Revenue and Forecast, by End-use (2025-2033)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2025-2033)
10.2.6.2. Market Revenue and Forecast, by Application (2025-2033)
10.2.6.3. Market Revenue and Forecast, by End-use (2025-2033)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2025-2033)
10.2.7.2. Market Revenue and Forecast, by Application (2025-2033)
10.2.7.3. Market Revenue and Forecast, by End-use (2025-2033)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2025-2033)
10.3.2. Market Revenue and Forecast, by Application (2025-2033)
10.3.3. Market Revenue and Forecast, by End-use (2025-2033)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2025-2033)
10.3.4.2. Market Revenue and Forecast, by Application (2025-2033)
10.3.4.3. Market Revenue and Forecast, by End-use (2025-2033)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2025-2033)
10.3.5.2. Market Revenue and Forecast, by Application (2025-2033)
10.3.5.3. Market Revenue and Forecast, by End-use (2025-2033)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2025-2033)
10.3.6.2. Market Revenue and Forecast, by Application (2025-2033)
10.3.6.3. Market Revenue and Forecast, by End-use (2025-2033)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2025-2033)
10.3.7.2. Market Revenue and Forecast, by Application (2025-2033)
10.3.7.3. Market Revenue and Forecast, by End-use (2025-2033)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2025-2033)
10.4.2. Market Revenue and Forecast, by Application (2025-2033)
10.4.3. Market Revenue and Forecast, by End-use (2025-2033)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2025-2033)
10.4.4.2. Market Revenue and Forecast, by Application (2025-2033)
10.4.4.3. Market Revenue and Forecast, by End-use (2025-2033)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2025-2033)
10.4.5.2. Market Revenue and Forecast, by Application (2025-2033)
10.4.5.3. Market Revenue and Forecast, by End-use (2025-2033)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2025-2033)
10.4.6.2. Market Revenue and Forecast, by Application (2025-2033)
10.4.6.3. Market Revenue and Forecast, by End-use (2025-2033)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2025-2033)
10.4.7.2. Market Revenue and Forecast, by Application (2025-2033)
10.4.7.3. Market Revenue and Forecast, by End-use (2025-2033)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2025-2033)
10.5.2. Market Revenue and Forecast, by Application (2025-2033)
10.5.3. Market Revenue and Forecast, by End-use (2025-2033)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2025-2033)
10.5.4.2. Market Revenue and Forecast, by Application (2025-2033)
10.5.4.3. Market Revenue and Forecast, by End-use (2025-2033)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2025-2033)
10.5.5.2. Market Revenue and Forecast, by Application (2025-2033)
10.5.5.3. Market Revenue and Forecast, by End-use (2025-2033)
Chapter 11. Company Profiles (2025-2033)
11.1. GE Healthcare
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Illumina, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. ASURAGEN, INC.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Abbott
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Dako A/S
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Exact Sciences Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Danaher Corporation (Cepheid, Inc.)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Decode Genetics, Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. QIAGEN
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Exagen Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Precision Biologics
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Celera Diagnostics LLC.
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Biogen
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Genelex
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. International Business Machines Corporation (IBM)
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
11.16. Genentech, Inc.
11.16.1. Company Overview
11.16.2. Product Offerings
11.16.3. Financial Performance
11.16.4. Recent Initiatives
11.17. 23andMe, Inc.
11.17.1. Company Overview
11.17.2. Product Offerings
11.17.3. Financial Performance
11.17.4. Recent Initiatives
Chapter 12. Research Methodology (2025-2033)
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix (2025-2033)
13.1. About Us
13.2. Glossary of Terms
著作権 ©2022 無断複写・転載を禁じます
